Summary of change in the 1.2013 version of the Guidelines for the Bladder Cancer from the 2.2012 version include:
BL-1
Primary evaluation/surgical treatment.
3rd bullet was revised as "f sessile, high grade cytology or suspicious for high grade or tis."
